- Home
- ADM vs DXCM Comparison
ADM vs DXCM Comparison
Compare ADM & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADM
- DXCM
- Stock Information
- Founded
- ADM 1902
- DXCM 1999
- Country
- ADM United States
- DXCM United States
- Employees
- ADM N/A
- DXCM N/A
- Industry
- ADM Packaged Foods
- DXCM Medical/Dental Instruments
- Sector
- ADM Consumer Staples
- DXCM Health Care
- Exchange
- ADM Nasdaq
- DXCM Nasdaq
- Market Cap
- ADM 23.1B
- DXCM 34.1B
- IPO Year
- ADM N/A
- DXCM 2005
- Fundamental
- Price
- ADM $54.94
- DXCM $83.52
- Analyst Decision
- ADM Hold
- DXCM Strong Buy
- Analyst Count
- ADM 6
- DXCM 20
- Target Price
- ADM $50.00
- DXCM $98.50
- AVG Volume (30 Days)
- ADM 4.4M
- DXCM 3.8M
- Earning Date
- ADM 07-29-2025
- DXCM 07-30-2025
- Dividend Yield
- ADM 3.71%
- DXCM N/A
- EPS Growth
- ADM N/A
- DXCM N/A
- EPS
- ADM 2.81
- DXCM 1.33
- Revenue
- ADM $83,858,000,000.00
- DXCM $4,148,000,000.00
- Revenue This Year
- ADM N/A
- DXCM $16.74
- Revenue Next Year
- ADM $2.73
- DXCM $15.29
- P/E Ratio
- ADM $19.55
- DXCM $62.58
- Revenue Growth
- ADM N/A
- DXCM 9.11
- 52 Week Low
- ADM $40.98
- DXCM $57.52
- 52 Week High
- ADM $66.08
- DXCM $117.19
- Technical
- Relative Strength Index (RSI)
- ADM 62.94
- DXCM 49.26
- Support Level
- ADM $53.21
- DXCM $82.73
- Resistance Level
- ADM $55.58
- DXCM $85.92
- Average True Range (ATR)
- ADM 1.40
- DXCM 2.63
- MACD
- ADM -0.01
- DXCM -0.09
- Stochastic Oscillator
- ADM 71.55
- DXCM 54.33
About ADM Archer-Daniels-Midland Company
Archer-Daniels-Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. The company is also one of the largest grain merchandisers through its extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients and is a large producer of corn-based sweeteners, starches, and ethanol.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.